Reconciliation of Non-GAAP Items (Unaudited)

Three Months Ended

March 31,

December 31,

(in thousands)

2021

2020

2020

Revenue

$

656,661

$

424,346

$

447,802

Nurse and allied solutions

Physician and leadership solutions

140,756

137,842

111,042

Technology and workforce solutions

88,528

40,273

72,427

$

885,945

$

602,461

$

631,271

Segment operating income (1)

Nurse and allied solutions

$

101,530

$

59,608

$

58,299

Physician and leadership solutions

21,216

14,569

16,910

Technology and workforce solutions

42,089

15,295

30,398

164,835

89,472

105,607

Unallocated corporate overhead (2)

23,919

15,491

16,313

Adjusted EBITDA (3)

$

140,916

$

73,981

$

89,294

Net income

$

70,378

$

12,965

$

9,308

Net income as a % of revenue

7.9 %

2.2 %

1.5 %

Income tax expense (benefit)

25,080

11,724

(3,330)

Income before income taxes

95,458

24,689

5,978

Interest expense, net, and other (5)

8,944

11,054

22,681

Income from operations

104,402

35,743

28,659

Operating margin (6)

11.8 %

5.9 %

4.5 %

Depreciation and amortization

23,254

20,089

23,670

Depreciation (included in cost of revenue) (7)

471

145

440

Share-based compensation

9,287

4,927

5,419

Acquisition, integration, and other costs (8)

3,502

13,077

31,106

Adjusted EBITDA (3)

$

140,916

$

73,981

$

89,294

Adjusted EBITDA margin (4)

15.9 %

12.3 %

14.1 %

1

Reconciliation of Non-GAAP Items (Unaudited)

Continued from page 1

Three Months Ended

March 31,

December 31,

2021

2020

2020

Net income

$

70,378

$

12,965

$

9,308

Adjustments:

Amortization of intangible assets

15,201

13,431

15,746

Acquisition, integration, and other costs (8)

3,502

13,077

31,106

Fair value changes of equity investments and instruments (5)

(1,271)

1,298

-

Debt financing related costs

158

-

11,513

Tax effect of above adjustments

(4,574)

(7,230)

(15,175)

Tax effect of COLI fair value changes (9)

(1,086)

5,255

(2,403)

Excess tax benefits related to equity awards (10)

(676)

(1,221)

(813)

Restructuring tax benefits (11)

-

-

(1,615)

Adjusted net income (12)

$

81,632

$

37,575

$

47,667

GAAP diluted net income per share (EPS)

$

1.47

$

0.27

$

0.19

Adjustments

0.23

0.52

0.81

Adjusted diluted EPS (13)

$

1.70

$

0.79

$

1.00

2

Reconciliation of Non-GAAP Items (Unaudited)

  1. Segment operating income represents net income plus interest expense (net of interest income) and other, income tax expense (benefit), depreciation and
    amortization, depreciation (included in cost of revenue), unallocated corporate overhead, acquisition, integration, and other costs, and share-based compensation.
  2. Unallocated corporate overhead (as presented in the tables above) consists of unallocated corporate overhead (as reflected in our quarterly and annual financial statements filed with the SEC) less acquisition, integration, and other costs.
  3. Adjusted EBITDA represents net income plus interest expense (net of interest income) and other, income tax expense (benefit), depreciation and amortization, depreciation (included in cost of revenue), acquisition, integration, and other costs, restructuring expenses, extraordinary legal expenses, and share-based compensation. Management believes that adjusted EBITDA provides an effective measure of the Company's results, as it excludes certain items that management believes are not indicative of the Company's operating performance. Adjusted EBITDA is not intended to represent cash flows for the period, nor has it been presented as an alternative to income from operations or net income as an indicator of operating performance. Although management believes that some of the items excluded from adjusted EBITDA are not indicative of the Company's operating performance, these items do impact the statement of comprehensive income, and management therefore utilizes adjusted EBITDA as an operating performance measure in conjunction with GAAP measures such as net income.
  4. Adjusted EBITDA margin represents adjusted EBITDA divided by revenue.
  5. Changes in the fair value of equity investments and instruments are recognized in interest expense, net, and other. Since the changes in fair value are unrelated to the Company's operating performance, we exclude the impact from the calculation of adjusted net income and adjusted diluted EPS.
  6. Operating margin represents income from operations divided by revenue.
  7. A portion of depreciation expense for AMN Language Services (formerly known as Stratus Video, which was acquired in February 2020 and has since been rebranded) is included in cost of revenue. We exclude the impact of depreciation included in cost of revenue from the calculation of adjusted EBITDA.
  8. Acquisition, integration, and other costs include acquisition and integration costs, net changes in the fair value of contingent consideration liabilities for recently acquired companies, extraordinary legal expenses, and restructuring expenses, which we exclude from the calculation of adjusted EBITDA, adjusted net income, and adjusted diluted EPS because we believe that these expenses are not indicative of the Company's operating performance. Acquisition, integration, and other costs for the three months ended March 31, 2020 include advisory fees contingent upon closing of the Stratus Video acquisition of $5,000,000. Acquisition, integration, and other costs for the three months ended December 31, 2020 include a net increase in the fair value of contingent consideration liabilities for recently acquired companies of $6,600,000 and extraordinary legal expenses of approximately $20,000,000. The extraordinary legal expenses primarily relate to an increase to the Company's legal reserve during the fourth quarter of 2020 for a wage and hour claim.
  9. The Company records net tax expense (benefit) related to the income tax treatment of the fair value changes in the cash surrender value of its company owned life insurance. Since this change in fair value is unrelated to the Company's operating performance, we excluded the impact on adjusted net income and adjusted diluted EPS.

3

Reconciliation of Non-GAAP Items (Unaudited)

Continued from page 3

  1. The consolidated effective tax rate is affected by the recording of excess tax benefits and tax deficiencies relating to equity awards vested and exercised during the period. As a result of the adoption of a new accounting pronouncement on January 1, 2017, the Company no longer records excess tax benefits and tax deficiencies to additional paid-in capital, but such excess tax benefits and tax deficiencies are now recognized in income tax expense. The magnitude of the impact of excess tax benefits and tax deficiencies generated in the future, which may be favorable or unfavorable, is dependent upon the Company's future grants of share- based compensation, the Company's future stock price on the date awards vest or exercise in relation to the fair value of the awards on the grant date or the exercise behavior of the Company's stock appreciation rights holders. Since these excess tax benefits and tax deficiencies are largely unrelated to our income before taxes and are unrepresentative of our normal effective tax rate, we excluded their impact in the calculation of adjusted net income and adjusted diluted EPS.
  2. The Company recorded a restructuring tax benefit during the three months ended December 31, 2020, which was related to the acquisition of Stratus Video. Since this benefit is largely unrelated to our income before taxes and is unrepresentative of our normal effective tax rate, we excluded its impact in the calculation of adjusted net income and adjusted diluted EPS.
  3. Adjusted net income represents GAAP net income excluding the impact of the (A) amortization of intangible assets, (B) acquisition, integration, and other costs, (C) extraordinary legal expenses, (D) changes in fair value of equity investments and instruments, (E) deferred financing related costs, (F) tax effect, if any, of the foregoing adjustments, (G) excess tax benefits and tax deficiencies relating to equity awards vested and exercised since January 1, 2017, and (H) net tax expense (benefit) related to the income tax treatment of fair value changes in the cash surrender value of its company owned life insurance, and (I) restructuring tax benefits. Management included this non-GAAP measure to provide investors and prospective investors with an alternative method for assessing the Company's operating results in a manner that is focused on its operating performance and to provide a more consistent basis for comparison between periods. However, investors and prospective investors should note that this non-GAAP measure involves judgment by management (in particular, judgment as to what is classified as a special item to be excluded in the calculation of adjusted net income). Although management believes the items in the calculation of adjusted net income are not indicative of the Company's operating performance, these items do impact the statement of comprehensive income, and management therefore utilizes adjusted net income as an operating performance measure in conjunction with GAAP measures such as GAAP net income.
  4. Adjusted diluted EPS represents adjusted net income divided by diluted weighted average common shares outstanding. Management included this non-GAAP measure to provide investors and prospective investors with an alternative method for assessing the Company's operating results in a manner that is focused on its operating performance and to provide a more consistent basis for comparison between periods. However, investors and prospective investors should note that this non-GAAP measure involves judgment by management (in particular, judgment as to what is classified as a special item to be excluded in the calculation of adjusted net income). Although management believes the items in the calculation of adjusted net income are not indicative of the Company's operating performance, these items do impact the statement of comprehensive income, and management therefore utilizes adjusted diluted EPS as an operating performance measure in conjunction with GAAP measures such as GAAP diluted EPS.

4

Reconciliation of Guidance Operating Margin to Guidance Adjusted EBITDA Margin

Three Months Ending

June 30, 2021

Low (1)

High (1)

Operating margin

10.5%

11.0%

Depreciation and amortization

2.9%

2.9%

EBITDA margin

13.4%

13.9%

Share-based compensation

0.7%

0.7%

Acquisition, integration, and other costs

0.3%

0.3%

Adjusted EBITDA margin

14.4%

14.9%

(1) Guidance percentage metrics are approximate.

5

Attachments

  • Original document
  • Permalink

Disclaimer

AMN Healthcare Services Inc. published this content on 06 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 May 2021 14:51:01 UTC.